SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCompre Grp.28 Regulatory News (RG62)

Share Price Information for Compre Grp.28 (RG62)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
RG62 Live PriceLast checked at - London Stock Exchange

Intraday Compre Grp.28 Share Chart

Board and Senior management changes

7 Feb 2025 17:00

RNS Number : 3907W
Compre Group Holdings Limited
07 February 2025
 

 

07 February 2025

 

Board and Senior management changes

 

Compre Group Holdings Limited, the Bermuda-domiciled international specialty reinsurance group, announces that Emmanuel Clarke will be resigning as Chairman and Non-Executive director on the 28 February 2025. The Board would like to thank Mr. Clarke for his significant contribution to the development of the Group over the last 4 years and to wish him well as he takes on an executive role with Intact Financial Corporation. Jonathan Reiss will be the acting Chairman in the interim.

 

The Group also announces that Derrick Estes has replaced Rhonda Ramparas as Non-Executive director representing BCi on the Board.

 

In addition, Dan Fiehn, Group COO, left the company with effect from 31st January 2025.

 

 

 

- Ends -

 

For further information please contact:

Compre

David Haggie / Richard Adams / Olivia Thomson, Haggie Partners

compre@haggie.co.uk 

+44 20 7562 4444

 

About Compre:

Compre is a global specialty reinsurer providing capital and liability solutions for its clients giving certainty to prior year development. It has over 30 years of experience in the acquisition and management of discontinued and prior year non-life insurance and reinsurance portfolios. Compre has experience of acquiring most classes of direct and reinsurance business, including general liability, marine and motor liability, and US APH and workers' compensation. Compre has operations in Bermuda, Finland, Germany, Malta, the UK, the USA and at Lloyd's of London.

 

www.compre-group.com

 

Cautionary note on forward-looking statements

This announcement may contain forward-looking statements. All statements other than statements of historical fact included in this announcement are forward-looking statements. Forward-looking statements express the Issuer's current expectations and projections relating to its financial condition, results of operations, plans, objectives, future performance and business. Such forward-looking statements are based on numerous assumptions regarding the Issuer's present and future business strategies and the environment in which it will operate in the future. No representation is made or will be made that any "forward-looking" statements will be achieved or will prove to be correct. Actual events or conditions may differ materially from such assumptions. Similarly no representation is given that the assumptions disclosed in this announcement upon which forward-looking statements may be based are reasonable. Past performance is not a reliable indicator of future performance. The recipient acknowledges that circumstances may change without notice and the contents of this announcement may become outdated as a result.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRSSEFDWEISEDE
Date   Source Headline
8th Jun 20263:16 pmRNSSenior Management Change
14th Apr 20269:02 amRNSCompre announces FY 2025 results
6th Feb 202612:11 pmRNSCompre Appoints David Atkins as Deputy CEO
12th Nov 20258:00 amRNSSenior Management Change
30th Sep 20257:56 amRNSInterim Financial Report - 30 June 2025
14th May 202511:17 amRNSCompre completes portfolio transfer from Ethias
17th Apr 20257:56 amRNSCompre announces FY 2024 results
16th Apr 20259:00 amRNSCompre acquires Covéa US subsidiary
13th Mar 20252:10 pmRNSCompre appoints John Howard as chairman
7th Feb 20255:00 pmRNSBoard and Senior management changes
12th Sep 20248:00 amRNSInterim Financial Report - 30 June 2024
22nd Aug 20245:19 pmRNSCompre and Accelerant execute legacy transaction
15th Aug 20247:00 amRNSCompre announces change of registered address
3rd Jun 20247:00 amRNSCompre reports record results in ‘landmark’ year
10th Jan 20249:00 amRNSCompre acquires two European liability portfolios
30th Nov 20234:37 pmRNSCompre appoints two new members to Group Board
11th Oct 20232:12 pmRNSInterim Financial Report - 30 June 2023
10th Oct 20234:55 pmRNSInterim Financial Report - 30 June 2023
4th Sep 20239:00 amRNSCompre completes acquisition of Covéa subsidiary
3rd Jul 20231:15 pmRNSSiriusPoint and Compre complete LPT transaction
22nd May 20237:40 amRNSCompre acquires workers’ comp portfolio from SUNZ
12th May 20231:45 pmRNSAudited Annual Financial Report - 31 December 2022
2nd Mar 20231:32 pmRNSCompre announces second deal with SiriusPoint
20th Oct 20227:00 amRNSCompre agrees to acquire subsidiary from Covéa
25th Aug 20228:22 amRNSCompre acquires further MedMal portfolio
15th Aug 20227:00 amRNSCompre acquires German liability portfolio

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.